PCSS-MOUD clinical experts have been working with local champions and multi-disciplinary teams on implementing evidence-based practices for the use and/or expansion of substance use disorder (SUD) treatment services, including medications for opioid use disorder (MOUD) within their healthcare system. PCSS-MOUD has provided access to lessons learned as well as trainings and resources that are shared with each of the participating clinical sites to help support their overall implementation. Please reference the information below to also make use in your practice.
BMC OBAT Manual (nurse care manager model)
Business Plan for Integrating SUD into Primary Care
- Business Plan for Medication Assisted Treatment (MAT)
- Clark et al., 2011, The Evidence Doesn’t Justify Steps By State Medicaid Programs To Restrict Opioid Addiction Treatment With Bup: compared spending, services and mortality of 33,923 MA Medicaid beneficiaries receiving bup, methadone, drug-free tx, or no tx (2003-2007). Bup was associated with more services but $1330 lower mean annual spending than methadone. Mortality rates were similar for bup and methadone, but mortality was 75% higher among those receiving drug-free tx and more than twice as high as those receiving no treatment.
- Documentation & Charge Capture Process: Medications for Addiction Treatment
- Haddad et al., 2014, Bup Maintenance Treatment Retention Improves Preventive Primary Care Screenings when Integrated into Urban FQHCs: examined quality health indicators (screenings for HCV, HIV, STIs, breast cancer, etc.) from 9 FQHC of 266 OUD patients initiating buprenorphine (2007-2008). Achieving greater than 80% (recommended) of QHIs was positively and independently associated with 3 month or greater bup retention and bup prescription by PCP rather than addiction psychiatrist.
Clinic Workflow Model
Induction Models
- Boston Medical Center OBAT Policy and Procedure Manual
- Buprenorphine Treatment Staging (BMC OBAT)
- Clinical Tools: COWS Scale
- Levels of Integrated Care
- Fentanyl Guidance: Practice-Based Guidelines: Buprenorphine in the Age of Fentanyl (PCSS Guidance)
- Clinical Pathway for Medication for Addiction Treatment
Intake/Follow Up Templates (for modification)
PCSS-MOUD Core Curriculum on Pain
Learn more about the PCSS-MOUD Core Curriculum on Pain
PCSS-MOUD Mentor Program
Learn more about the PCSS-MOUD Mentor Program
Peer Recovery Resources
Program Considerations for SUD Treatment
Quality Improvement Indicator Worksheet (to monitor launch)
SBIRT Resources to Address Prevention and Early Intervention
- PCSS-MOUD Training: Screening, Brief Intervention, Referral to Treatment (SBIRT) for Substance Use Disorders in Primary Care Settings: This module describes the SBIRT model (Screening, Brief Intervention, Referral to Treatment), an evidence-based practice that has shown significant success in varied clinic settings at reducing alcohol and illicit substance use.
- Instrument: TAPS Tool – This link is a good tool for alcohol, tobacco, and drug screening, very brief, and specifically developed for primary care settings.
- SAMHSA Resources for Screening, Brief Intervention, and Referral to Treatment (SBIRT)
- “SBIRT Model” for primary care: The Addiction Professional’s Guide to Screening, Brief Intervention, Brief Intervention and Referral to Treatment (SBIRT)
- SBIRT Pocket card
- Systems-Level Implementation of Screening, Brief Intervention, and Referral to Treatment Tips 33
- What is SBIRT (Video)
SUD 101 Education Modules
SUD Screening Tools
-
- AUDIT C – Cards Male Norms (PDF)
- AUDIT C – Cards Female Norms (PDF)
- AUDIT C – Measuring and Scoring (PDF)Screenings:
- The Clinicians Screening Tool for Drug Use in General Medical Settings from the National Institute for Drug Abuse (NIDA) This tool guides clinicians through a series of questions to identify risky substance use in their adult patients. At the end of the question and answer, it provides the clinician and patient with a list of information including: treatment options and vulnerabilities for the drug associated with the high score throughout the test. In addition, withdrawal symptoms to the particular drug and its symptoms when combined with alcohol are listed. At the end, the patient will be given a “substance involvement score – risk level” which will determine the next steps. (which include: 1) provide feedback on the screening results, 2) advise, assess and assist, 3) arrange referral, and 4) offering continuing support).
- Drug Abuse Screening Test (DAST)
- Guideline for Alcohol and Substance Use Screening, Brief Intervention, Referral to Treatment (SBIRT)
Tapering Protocols
Buprenorphine Training Information
Learn more on the Buprenorphine Training Page.
